A Study Comparing the Efficacy and Safety of Nivolumab in Combination With Bacillus Calmette-Guerin (BCG) Versus BCG Alone in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC)
Clinical trial NCT04149574 · TERMINATED
Trial details
- NCT number
- NCT04149574
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-15
- Primary completion
- 2023-10-31
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.